# Tianjin Pharmaceutical Group International Holdings

> Tianjin Pharmaceutical Group International Holdings is a VC fund backing Video and Consumer. See 3 investments, round sizes, portfolio. Updated Oct 2026.

- Type: VC Fund
- Location: Tianjin, China
- Total investments: 3
- Last investment: Mar 2021
- Lead investor: 33%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/company/天津市医药集团有限公司
- Website: http://www.pharm.cn/

Tianjin Pharmaceutical Group International Holdings is a VC fund in Tianjin focused on Video and Consumer. Tianjin Pharmaceutical Group International Holdings a large pharmaceutical enterprise in China. They specializes in the research, development, production, and sale of pharmaceutical products.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Video | 1 | 33% |
| Consumer | 1 | 33% |
| Health Care | 1 | 33% |
| Neuroscience | 1 | 33% |
| Therapeutics | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Huiyong Pharmaceutical | Huiyong Pharmaceutical is a platform-based R&D company that focuses on key technologies for high-end preparations and unmet clinical needs. | $30.9M | Series A | Mar 01, 2021 |  |
| NeuralStem | Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research hasallowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases. | $20M | Post-IPO Equity | Dec 12, 2016 | http://www.neuralstem.com |
| Baofeng Mojing | Baofeng Mojing Chinese video streaming company. Baofeng Mojing appears to be a few steps ahead of the market in that its product is already available to consumers. It’s also one of the cheapest VR experiences on the market, | $35M | Series B | Jan 22, 2016 | http://baofengmojing.cn |

3 of 3 investments shown.

## Co-investors
- [Aisidi](https://shizune.co/investors/profile/aisidi) — VC Fund, 1 deal together
- [Baofeng Xinying](https://shizune.co/investors/profile/baofeng-xinying) — VC Fund, 1 deal together
- [CITIC Capital Holdings](https://shizune.co/investors/profile/citic-capital-holdings) — VC Fund, 1 deal together
- Haohai Capital — VC Fund, 1 deal together
- [Huayi Brothers Media Group](https://shizune.co/investors/profile/huayi-brothers-media-group) — VC Fund, 1 deal together
- Ningbo Xinhui — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Tianjin Pharmaceutical Group International Holdings invest in?

Tianjin Pharmaceutical Group International Holdings invests primarily in Video, Consumer and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Tianjin Pharmaceutical Group International Holdings last invest?

The most recent investment recorded for Tianjin Pharmaceutical Group International Holdings closed in Mar 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co